Marvell Technology executive Chris Koopmans sells 10000 shares, realizing approximately 2620500 USD。
Article
Marvell Technology President and Chief Operating Officer Chris Koopmans sells shares 10000 shares, realizing approximately 2620500 USD BlockBeats reported that October 2, Marvell Technology President and Chief Operating Officer Chris Koopmans filed a Form statement of changes in beneficial ownership.October 1, President and Chief Operating Officer Chris Koopmans sold through 1 transactions in total, selling 10000 shares of common stock at a transaction price of 262.05 USD, with a weighted average price of approximately 262.05 USD, realizing approximately 2620500 USD. After the sale, Koopmans directly held 207941 shares of the company's common stock. The sale was executed under a Rule 10b5-1 trading plan.
Original link https://m.theblockbeats.info/flash/370001
Key points
01
BlockBeats reported that October 2 Chris Koopmans filed a Form 4 statement of changes in beneficial ownership.
02
October 1, Chris Koopmans sold through 1 transactions, selling 10000 shares of common stock.
03
Both the transaction price and weighted average price were 262.05 USD, realizing approximately 2620500 USD。
04
After the sale, Chris Koopmans directly held 207941 shares of the company's common stock.
05
The sale was executed under a Rule 10b5-1 trading plan.
AI-assisted interpretation
The following is analysis, separate from reported facts. Verify important claims independently.
This is a disclosure of a change in holdings involving a company executive's sale of shares. The disclosure shows that Chris Koopmans sold 10000 shares of Marvell Technology common stock and states that the transaction was executed under a Rule 10b5-1 plan.
Why it matters to readers
Investors can use this information to understand a publicly disclosed change in an executive's holdings, but the material does not explain the transaction's impact on the company's operations or share price.
Form 4 This is a document used by insiders of U.S. companies to disclose changes in their holdings; a Rule 10b5-1 trading plan is a prearranged trading plan.
Risks and unknowns
The provided material does not include the Form 4 original regulatory filing, so the complete transaction details cannot be independently verified.
The impact of the transaction on the share price or the company's operations cannot be determined from this material alone.
The provided material does not state when the Rule 10b5-1 plan was established or provide additional terms.
Related Developments
Loading event timeline…
Related concepts
Form 4
This term is not in the glossary yet. Browse related concepts in the glossary.
